MAKO Medical Forges Partnership with the CDC
May 13, 2021 13:58 ET | MAKO Medical
Raleigh, North Carolina, May 13, 2021 (GLOBE NEWSWIRE) -- MAKO Medical Laboratories, a national reference laboratory and leader in COVID-19 testing, today announced a comprehensive partnership with...
gmi logo.jpg
Point of Care Molecular Diagnostics Market revenue to cross USD 4.8 Bn by 2027: Global Market Insights Inc.
April 12, 2021 07:00 ET | Global Market Insights, Inc
Selbyville, Delaware, April 12, 2021 (GLOBE NEWSWIRE) -- According to latest report “Point of Care (PoC) Molecular Diagnostics Market by Technology (PCR, In Situ Hybridization, Sequencing,...
gmi logo.jpg
Point of Care Molecular Diagnostics Market revenue to cross USD 2.8 Bn by 2026: Global Market Insights, Inc.
September 21, 2020 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, Sept. 21, 2020 (GLOBE NEWSWIRE) -- According to latest report “PoC Molecular Diagnostics Market by Technology (PCR, In Situ Hybridization, Sequencing, Isothermal...
LogoPressRelease.jpg
Fluidigm and Next Gen Diagnostics Enter into Agreement to Improve the Efficiency of Pathogen Sample Preparation for Microbial Whole Genome Sequencing
March 03, 2020 08:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif. and HINXTON, United Kingdom, March 03, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an industry leader in microfluidics technology, and Next Gen...
LogoPressRelease.jpg
Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting
October 15, 2019 16:15 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 15, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation
September 09, 2019 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Logo (3).png
Oligonucleotide Synthesis Market Worth $2.9 Billion by 2024- Exclusive Report by Meticulous Research®
July 17, 2019 09:53 ET | Meticulous Market Research Pvt. Ltd.
London, July 17, 2019 (GLOBE NEWSWIRE) -- According to this latest publication from Meticulous Research®, the global oligonucleotide synthesis market is expected to grow at a CAGR of 10.5% from 2019...
LogoPressRelease.jpg
Fluidigm Introduces a Lower-Cost Workflow for Full-Length Single-Cell mRNA Sequencing on C1
July 31, 2018 08:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation, a leader in mass cytometry and microfluidics technologies, today announced a new full-length single-cell mRNA...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results
July 05, 2018 16:05 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass...
LogoPressRelease.jpg
Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
June 07, 2018 07:00 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic...